Showing results (161-170 of 215) with videos related to
Sort By:
Pageof 22
Anaesthesia|October 1, 1991
Rectus sheath and mesosalpinx block for laparoscopic sterilizationB E Smith, G H MacPherson, M de Jonge, et al.Complementary Therapies in Medicine|August 20, 2002
Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendationsH MacPherson, A White, M Cummings, et al.Lancet (London, England)|November 18, 1989
Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemiaS H Ralston, S J Gallacher, U Patel, et al.Arthritis and Rheumatism|October 11, 2001
Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026)K J Armour, R J van 't Hof, K E Armour, et al.Endocrinology|February 13, 2001
Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthaseK E Armour, K J Armour, M E Gallagher, et al.Annals of the Rheumatic Diseases|January 1, 1990
Hypercalcaemia in rheumatoid arthritis revisitedS H Ralston, W D Fraser, J Jankowski, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 8, 2001
COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone lossH M MacDonald, F A McGuigan, S A New, et al.Bone and Mineral|December 1, 1991
A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemiaS J Gallacher, S H Ralston, W D Fraser, et al.Bone and Mineral|February 1, 1991
Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancyW D Fraser, F C Logue, S J Gallacher, et al.Bone|October 26, 2002
Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphismsW Balemans, D Foernzler, C Parsons, et al.Pageof 22